BC
GBT

Brinker Capital’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Brinker Capital’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$374K Buy
+5,927
New +$407K 0.01% 779

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Brinker Capital's GBT Position: Q2 2020 in Review

Brinker Capital opened a new position in Global Blood Therapeutics, Inc. (GBT) in Q2 2020: 5,927 shares worth $374K. The stake represents 0.01% of the portfolio and ranks #779 among its holdings.

253 funds tracked by Wall St. Rank hold GBT as of Q2 2020.

  • Brinker Capital held 5,927 shares of Global Blood Therapeutics, Inc. worth $374K as of Q2 2020.
  • Global Blood Therapeutics, Inc. was a new Brinker Capital position in Q2 2020.
  • Global Blood Therapeutics, Inc. made up 0.01% of Brinker Capital's portfolio in Q2 2020, its #779 holding.
  • 253 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.